Search

everythinglearnresearchcommunity

for

Search:↓

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

The conference reported improvements in muscle volume, skin cancer diagnosis, facial and vaginal rejuvenation, and hair growth using various laser treatments.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

New treatments and technologies in laser medicine show promise for improving skin conditions, fat reduction, cancer treatment, wound healing, and hair restoration.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

Epigenetic changes control how adult stem cells work and can lead to diseases like cancer if they go wrong.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Some natural compounds from Iris plants can block enzymes related to certain disorders, with a few affecting both targeted enzymes.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Overactive signaling in hair follicles can lead to skin cancer.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Cell membrane-coated nanoparticles could improve gene therapy by enhancing delivery and targeting of nucleic acids.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Certain cancer drugs can cause skin issues like rashes and itching.